Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
04/2003
04/03/2003US20030064952 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
04/03/2003US20030064927 Regeneration of soft tissue; wound healing agents
04/03/2003US20030064919 Novel polypeptides and polynucleotides encoding same
04/03/2003US20030064493 Methods and means for modulating PGE synthase activity
04/03/2003US20030064475 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof
04/03/2003US20030064431 Complement receptor type 1 (cr1)-like sequences
04/03/2003US20030064426 Expression vector for use in the treatment of cancer and age-related defects
04/03/2003US20030064412 123 human secreted proteins
04/03/2003US20030064410 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids
04/03/2003US20030064369 Novel proteins and nucleic acids encoding same
04/03/2003US20030064122 Pharmaceutical compound, and an amount of a capsaicin compound to deter intranasal, oral, and intravenous abuse while having little or no irritating effect when administered orally or transdermally as directed
04/03/2003US20030064117 For oral administration, injection and topical application
04/03/2003US20030064114 For vasodilatation and inhibition of transplant rejection
04/03/2003US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
04/03/2003US20030064097 For delivery of drugs, nutrionals, cosmeceuticals and diagnostic agents
04/03/2003US20030064095 Microfabricated nanopore device for sustained release of therapeutic agent
04/03/2003US20030064088 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion
04/03/2003US20030064069 Specific binding members for TGFbeta1
04/03/2003US20030064067 Inducing differentiation and/or promoting proliferation of regulatory T cells, comprising allowing a CD3 agonist and a 4C8 antigen agonist to act on an immunocyte expressing CD3 and 4C8 antigens
04/03/2003US20030064063 For prophylaxis of type I hypersensitivity disease in a subject receiving immunotherapy
04/03/2003US20030064036 Coating and binding agent for pharmaceutical formulations with improved storage stability
04/03/2003CA2461806A1 Water-soluble phenylpyridazine derivatives and medicines containing the same
04/03/2003CA2461714A1 Treatment of chronic joint inflammation
04/03/2003CA2461666A1 Combination therapies for immune mediated diseases
04/03/2003CA2461630A1 Organoleptically acceptable intraorally disintegrating compositions
04/03/2003CA2461529A1 Recombinant anti-osteopontin antibody and use thereof
04/03/2003CA2461372A1 Dna sequences for human angiogenesis genes
04/03/2003CA2461305A1 Methods of suppressing microglial activation and systemic inflammatory responses
04/03/2003CA2461095A1 Process for making substituted pyrazoles
04/03/2003CA2461080A1 Solid-state forms of n-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl)pyrazole
04/03/2003CA2461044A1 Intraorally disintegrating valdecoxib compositions
04/03/2003CA2460953A1 Proteins associated with cell growth, differentiation, and death
04/03/2003CA2460344A1 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)
04/03/2003CA2460000A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
04/03/2003CA2459943A1 Androstanes as androgen receptor modulators
04/03/2003CA2458279A1 Modulation of vitamin storage
04/03/2003CA2453985A1 Receptors and membrane-associated proteins
04/03/2003CA2446904A1 Delivery of drug esters through an inhalation route
04/02/2003EP1298348A1 Bush, group of bush, suspension cross-member, vehicle, method for mounting a bush and method for mounting a group of bushes
04/02/2003EP1298206A1 Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
04/02/2003EP1297836A1 COMPOSITIONS CONTROLLING RELEASE pH RANGE AND/OR SPEED
04/02/2003EP1297828A1 Oral formulations for localized colonic release and the method of preparation thereof
04/02/2003EP1297172A2 Methods for producing modified glycoproteins
04/02/2003EP1297142A2 Dual specificity antibodies and methods of making and using
04/02/2003EP1297137A2 Gp286 nucleic acids and polypeptides
04/02/2003EP1297135A2 Pd-l2 molecules: novel pd-1 ligands and uses therefor
04/02/2003EP1297129A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
04/02/2003EP1297017A2 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
04/02/2003EP1297014A2 Transporters and ion channels
04/02/2003EP1297012A2 Novel fibroblast growth factors and nucleic acids encoding same
04/02/2003EP1297007A2 Mammalian protein phosphatases
04/02/2003EP1296996A1 Purine derivatives
04/02/2003EP1296978A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
04/02/2003EP1296976A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
04/02/2003EP1296975A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
04/02/2003EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors
04/02/2003EP1296971A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
04/02/2003EP1296967A1 Quinolinyl and benzothiazolyl ppar-gamma modulators
04/02/2003EP1296961A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
04/02/2003EP1296959A1 Methods and compositions utilizing quinazolinones
04/02/2003EP1296956A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
04/02/2003EP1296951A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis
04/02/2003EP1296949A2 Piperidine amides as modulators of chemokine receptor activity
04/02/2003EP1296946A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
04/02/2003EP1296940A1 Amidine derivatives as selective antagonists of nmda receptors
04/02/2003EP1296929A2 Modified forms of pharmacologically active agents and uses therefor
04/02/2003EP1296923A2 Aspirin-triggered lipid mediators
04/02/2003EP1296724A1 Bioadhesive composition and methods of preparation and use
04/02/2003EP1296709A1 Solubilised protein vaccines
04/02/2003EP1296702A1 Neuroprotective peptides
04/02/2003EP1296699A1 Therapeutic agents - iii
04/02/2003EP1296698A1 Therapeutic agents - ii
04/02/2003EP1296697A1 Therapeutic agents - i
04/02/2003EP1296692A1 Use of a formulation made of or containing at least one dissimilated milk serum
04/02/2003EP1296679A1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition
04/02/2003EP1296665A1 Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
04/02/2003EP1296652A1 Topical pharmaceutical formulations and methods of treatment
04/02/2003EP1296650A2 Methods and compositions for treating pain of the mucous membrane
04/02/2003EP1296644A2 Systems and methods for treating a mucosal surface
04/02/2003EP1296552A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5
04/02/2003EP1226143B1 Imidazopyridine derivatives used as phosphodiesterase vii inhibitors
04/02/2003EP1208100B1 Selective antagonists of a2b adenosine receptors
04/02/2003EP1135126A4 Myt1 kinase inhibitors
04/02/2003EP1131091B1 Treatment of viral hemorrhagic fever with protein c
04/02/2003EP1114051B1 INHIBITORS OF p38
04/02/2003EP1083886B1 Drug delivery system comprising a tightly compacted solid medicament stock
04/02/2003EP1030842B1 Metalloproteinase inhibitors
04/02/2003EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
04/02/2003EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
04/02/2003EP0934320B1 Naphthyridine derivatives
04/02/2003EP0880504B1 Heterocyclo-substituted imidazoles for the treatment of inflammation
04/02/2003EP0873295B1 Dimer-selective rxr modulators and methods for their use
04/02/2003EP0865445B1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
04/02/2003EP0770081B1 Heterocycle-condensed morphinoid derivatives
04/02/2003EP0587800B1 Immunomodulatory azaspiranes
04/02/2003CN1407985A Heterocyclic dihydropyrimidine as potassium path inhibitor
04/02/2003CN1407983A Tert-butyl-(7-methyl-imidazo [1,2-A] pyridine-3-yl)-amine derivatives
04/02/2003CN1407978A Polyhydroxystilbenes and stibene oxides as antisoriatic agents and protein kinase inhibitors
04/02/2003CN1407975A Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
04/02/2003CN1407973A Butyne diol derivatives
1 ... 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 ... 1272